Company / Shareholders' Equity
Avanos Medical, Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$778.2M
FY2025
5-year range
$778.2M / $1.3B
FY2021-FY2025
Trend
-6.1%
vs FY2024
Sector context
#98 of 166
Health Care
What the data says
At $778M, Avanos Medical, Inc.'s shareholders' equity ranks #98 of 166 in the Health Care sector. Shareholders' Equity has declined for 3 consecutive years, from $1.3B in FY2022 to $778M in FY2025.
Based on SEC 10-K filings.
$778M in FY2025 with a 5-year CAGR of -9.2%.
Declined from $1.2B to $778M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -15.5%
- 5-Year CAGR
- -9.2%
- 10-Year CAGR
- -
Sector benchmark
#98 of 166 in Health CareTop 59% of 166This company $778.2M Sector average $5.3B
▼
-85.2% below sector average
Key checks
Key Insights
- Avanos Medical, Inc.'s shareholders' equity has declined for 3 consecutive years.
- 5-year CAGR of -9.2%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 6.1% year-over-year.
- Ranks #98 out of 166 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $778.2M | -6.1% |
| FY2024 | $828.5M | -33.0% |
| FY2023 | $1.2B | -4.3% |
| FY2022 | $1.3B | +1.6% |
| FY2021 | $1.3B | +0.7% |
| FY2020 | $1.3B | -0.8% |
| FY2019 | $1.3B | -1.9% |
| FY2018 | $1.3B | +6.7% |
| FY2017 | $1.2B | +10.2% |
| FY2016 | $1.1B | +4.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026